FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to vascular surgery, and can be used in the treatment of patients with acute thromboembologic ischemia of the lower extremities. The method includes the introduction of a vasoactive drug, which is used as dexamethasone, which is injected intravenously at a dose of 8 mg in 200 ml of isotonic sodium chloride solution after reconstructive surgery, with a course of 4 to 6 days.
EFFECT: use of the invention makes it possible to improve the results of postoperative treatment of patients with acute ischemia of the lower extremities, to reduce mortality, the frequency of complications of both infectious and inflammatory genesis, to reduce the number of amputations, to shorten the duration of treatment.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF REPERFUSION COMPLICATIONS IN PATIENTS SURGERY FOR ACUTE LOWER LIMB ISCHEMIA | 2021 |
|
RU2778351C1 |
| THERAPY OF CHRONIC LOWER LIMB ISCHEMIA | 2008 |
|
RU2367477C1 |
| METHOD FOR COMBINED TREATMENT OF PATIENTS WITH ARTERIOSCLEROSIS OBLITERANS OF LOWER EXTREMITIES | 2012 |
|
RU2505300C1 |
| METHOD OF TREATING CHRONIC LOWER LIMB ISCHEMIA OF IIB - IV STAGES | 2007 |
|
RU2351334C1 |
| METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION AT PROGRESSIVE CURRENT OF OBJECTIVE ATHEROSCLEROSIS OF VESSEL LIMBS | 2016 |
|
RU2624870C1 |
| METHOD FOR DEVELOPING TREATMENT TACTICS FOR ACUTE ARTERIAL THROMBOSES ASSOCIATED WITH COVID-19 | 2021 |
|
RU2773295C1 |
| METHOD FOR THE TREATMENT OF ACUTE ARTERIAL THROMBOSIS ASSOCIATED WITH COVID-19 | 2022 |
|
RU2795534C1 |
| METHOD OF TREATING PATIENTS WITH OBLITERATING DISEASES OF LOWER EXTREMITY ARTERIES | 2013 |
|
RU2523412C1 |
| METHOD FOR ARTERIAL PLASTY OF FEMORAL-POPLITEAL SEGMENT AT THE ABSENCE OF AUTOLOGOUS TRANSPLANT | 2004 |
|
RU2280412C2 |
| METHOD OF TREATING PATIENTS WITH POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2807874C1 |
